CONGRESS COVERAGE: Renal Sympathetic Denervation for Resistant Hypertension: Symplicity HTN-3 and the Power of Placebo

Open Hypertension Journal - United Arab Emirates
doi 10.2174/1876526201406010018
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Bentham Science Publishers Ltd.

Related search

Renal Denervation for Resistant Hypertension—the Symplicity HTN-1 Study

The Lancet
Medicine
2014English

Renal Sympathetic Denervation for Treatment of Drug-Resistant Hypertension: One-Year Results From the Symplicity HTN-2 Randomized, Controlled Trial

Circulation
Cardiovascular MedicinePhysiologyCardiology
2012English

Expanding the Targets of Renal Sympathetic Denervation: From Resistant Hypertension to Atrial Fibrillation

Journal of Hypertension- Open Access
2013English

Catheter-Based Renal Sympathetic Denervation – Long-Term Symplicity™ Renal Denervation Clinical Evidence, New Data and Future Perspectives

Interventional Cardiology Review
Cardiovascular MedicineCardiology
2013English

A Controlled Trial of Renal Denervation for Resistant Hypertension

Journal of Vascular Surgery
SurgeryCardiovascular MedicineCardiology
2014English

Renal Sympathetic Denervation: Renal Nerve Stimulation

English

Response to Letter Regarding Article, "Ambulatory Blood Pressure Changes After Renal Sympathetic Denervation in Patients With Resistant Hypertension"

Circulation
Cardiovascular MedicinePhysiologyCardiology
2014English

Renal Denervation in Patient With Resistant Hypertension: A Case Report

Srce i krvni sudovi
2012English

Joint UK Societies’ 2014 Consensus Statement on Renal Denervation for Resistant Hypertension

Heart
Cardiovascular MedicineCardiology
2014English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy